Quantum Genomics Société Anonyme (QNNTF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -20.21 Million | -17.01 Million | -14.67 Million | -10.4 Million | -10.9 Million |
| Net Income | -3.17 Million | -24.93 Million | -17.35 Million | -19.85 Million | -9.07 Million | -11.99 Million |
| Depreciation & Amortization | - | 282.44 Thousand | 390 Thousand | 167.62 Thousand | 49 Thousand | 19.01 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1.56 Million | 1.48 Million | 859 Thousand | - |
| Change in working capital | - | 4.27 Million | -2.33 Million | 1.33 Million | -1.37 Million | 809 Thousand |
| Other non-cash items | 3.17 Million | 450.71 Thousand | 718 Thousand | 3.67 Million | -211 Thousand | 261.03 Thousand |
| Investing Cash Flow | - | -152.53 Thousand | -45 Thousand | -502.87 Thousand | -271 Thousand | -231 Thousand |
| Investments in PPE | - | - | -45 Thousand | -502.87 Thousand | -376 Thousand | -16 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -32.53 Thousand | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 105 Thousand | - |
| Other Investing Activities | - | -120 Thousand | - | 7329.00 | - | -215 Thousand |
| Financing Cash Flow | - | 17.21 Million | 3.46 Million | 34.73 Million | 7.04 Million | 14.84 Million |
| Debt repayment | - | -31.62 Thousand | -2.62 Million | -33.03 Thousand | -338 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 17.18 Million | 961.59 Thousand | 34.87 Million | 7.38 Million | - |
| Other Financing Activities | - | 31.62 Thousand | 840 Thousand | -106.44 Thousand | -337 Thousand | 14.84 Million |
| Accounts receivables | - | 64.06 Thousand | 763 Thousand | -1 Million | - | - |
| Accounts payables | - | - | 871.8 Thousand | 2.37 Million | - | - |
| Inventory | - | - | - | -1.41 Million | 89 Thousand | -178 Thousand |
| Other working capital | - | -5.34 Million | -3.09 Million | 1.38 Million | -274.81 Thousand | 987 Thousand |
| Cash at beginning of period | 10.4 Million | 13.55 Million | 27.15 Million | 2.31 Million | 14.79 Million | 11.08 Million |
| Cash at end of period | 11.13 Million | 10.4 Million | 13.55 Million | 33.22 Million | 11.16 Million | 14.79 Million |
| Capital Expenditure | - | - | -45 Thousand | -502.87 Thousand | -376 Thousand | -16 Thousand |
| Effect of forex changes on cash | - | - | -1.28 | -0.21 | - | - |
| Net cash flow / Change in cash | 736.14 Thousand | -3.15 Million | -13.6 Million | 30.9 Million | -3.63 Million | 3.7 Million |
| Free Cash Flow | - | -20.21 Million | -17.06 Million | -15.17 Million | -10.78 Million | -10.91 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -592.67 Thousand | -3.17 Million | -592.67 Thousand | -992.8 Thousand | -992.8 Thousand | -24.93 Million |
| Depreciation & Amortization | - | - | - | 2238.00 | 2238.00 | 282.44 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 4.91 Million | 4.91 Million | 4.27 Million |
| Other non-cash items | 592.67 Thousand | 3.17 Million | 592.67 Thousand | -7.74 Million | -7.74 Million | 450.71 Thousand |
| Investing Cash Flow | - | - | - | -3406.00 | -3406.00 | -152.53 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -32.53 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -3406.00 | -3406.00 | -120 Thousand |
| Financing Cash Flow | - | - | - | - | - | 17.21 Million |
| Debt repayment | - | - | - | - | - | -31.62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 17.18 Million |
| Other Financing Activities | - | - | - | - | - | 31.62 Thousand |
| Accounts receivables | - | - | - | - | - | 64.06 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | 4.91 Million | 4.91 Million | -5.34 Million |
| Cash at beginning of period | - | 10.4 Million | - | - | - | 13.55 Million |
| Cash at end of period | - | 11.13 Million | - | -3.82 Million | -3.82 Million | 10.4 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 736.14 Thousand | - | -3.82 Million | -3.82 Million | -3.15 Million |
| Free Cash Flow | - | - | - | -3.81 Million | -3.81 Million | -20.21 Million |
0LO3
PRRUF
0H68
HNNA
PXDT
ARCAY